Soft Tissue Sarcoma Adult

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over

Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Sarcomas and DDR-Inhibition; a Combined Modality Study

Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma

Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Pre-operative RadiothErapy for Soft Tissue SarcOmas

Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma

Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas

Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)

Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients

Radiation Effects on Bone